A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.
Vaitaitis GM, Yussman MG, Wagner DH. A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2019 07 15; 332:8-15.